List view / Grid view

News

CHMP recommends indication for the use of Trajenta® (linagliptin) tablets

24 September 2012 | By Boehringer Ingelheim / Eli Lilly and Company

Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a Positive Opinion from the European Medicines Agency’s (EMA) medicinal committee recommending expanding the therapeutic indication for the DPP-4 inhibitor Trajenta® (linagliptin). If approved by the European Commission, this will expand the indicated use of Trajenta® by…

Registration opens for Pittcon 2013

21 September 2012 | By Pittcon

The Registration Committee is pleased to announce that conferee registration is now open for Pittcon 2013, which will be held March 17-21, 2013...